Quest Diagnostics (DGX) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $9.8 billion.
- Quest Diagnostics' Retained Earnings rose 666.88% to $9.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 billion, marking a year-over-year increase of 666.88%. This contributed to the annual value of $9.4 billion for FY2024, which is 606.23% up from last year.
- Per Quest Diagnostics' latest filing, its Retained Earnings stood at $9.8 billion for Q3 2025, which was up 666.88% from $9.7 billion recorded in Q2 2025.
- In the past 5 years, Quest Diagnostics' Retained Earnings ranged from a high of $10.2 billion in Q2 2021 and a low of -$22.0 million during Q4 2022
- Over the past 5 years, Quest Diagnostics' median Retained Earnings value was $8.8 billion (recorded in 2023), while the average stood at $8.0 billion.
- In the last 5 years, Quest Diagnostics' Retained Earnings plummeted by 5714.29% in 2022 and then surged by 4021363.64% in 2023.
- Over the past 5 years, Quest Diagnostics' Retained Earnings (Quarter) stood at -$14.0 million in 2021, then plummeted by 57.14% to -$22.0 million in 2022, then surged by 40213.64% to $8.8 billion in 2023, then rose by 6.06% to $9.4 billion in 2024, then rose by 5.1% to $9.8 billion in 2025.
- Its Retained Earnings was $9.8 billion in Q3 2025, compared to $9.7 billion in Q2 2025 and $9.5 billion in Q1 2025.